XOMA Royalty Corp.
Key Metrics
- Previous Close
- $40.17
- 52-Week Range
- $22.29 – $45.22
- Market Cap
- $710.16M
- P/E (TTM)
- 25.59
- EPS (TTM)
- 1.57
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 5.15
- PEG Ratio
- —
- Return on Equity
- 34.23%
- Return on Assets
- 1.28%
- Gross Margin
- 99.04%
- Operating Margin
- -3.90%
- Profit Margin
- 69.63%
- Current Ratio
- 3.59
- Debt/Equity
- 1.10
- Total Debt
- $124.73M
- Free Cash Flow
- $-13.07M
- Revenue Growth
- -22.60%
- Earnings Growth
- 207.90%
- Enterprise Value
- $562.48M
Market Snapshot
About
XOMA Royalty Corporation is a biotechnology royalty aggregator that acquires the right to milestone and royalty payments associated with commercialized and clinical-stage drug products. The company provides non-dilutive funding to biotechnology companies in exchange for economic rights to future product revenues. XOMA manages a diversified portfolio of assets across multiple therapeutic areas and development stages.